antibody therapy / Strohner, Pavel / Sarrach, Dieter / Reich, Jens G. / Staatz, Antonia / Schäfer, Astrid / Steiß, Jens-Oliver / Häupl, Thomas / Becher, Gunther -- 2.6 Genotypic prediction of HIV-1 tropism from plasma and peripheral blood mononuclear cells in the clinical routine laboratory / Paar, Christian / Geit, Maria / Stekel, Herbert / Berg, Jörg -- 2.7 Expression of a subset of microRNAs in clinically non-functioning pituitary adenomas correlates with tumor size / Butz, Henriett / Likó, István / Czirják, Sándor / Igaz, Péter / Korbonits, Márta / Rácz, Károly / Patócs, Attila -- 2.8 Serological markers of gastric pathology / Caleffi, Alberta -- 2.9 BNP as a biomarker of cardiac impairment in neonates with congenital heart diseases / Cantinotti, Massimiliano / Murzi, Bruno / Storti, Simona / Clerico, Aldo -- 2.10 Are 25-hydroxyvitamin D assays fit for purpose? / Carter, Graham D. -- 2.11 Update on multiple sclerosis / Cross, Anne H. -- 2.12 Microalbuminuria and urinary retinol binding protein as markers of subtle renal injury in visceral leishmaniasis: sensitivity, specificity and predictive values of the immunoturbidimetric technique / Elnojomi, Nuha A.A. / Musa, Ahmed M. / Younis, Brima M. / Elfaki, Mohammed E. / El-Hassan, Ahmed M. / Khalil, Eltahir A. -- 2.13 Occult hepatitis B virus infection: diagnosis and significance / Gerlich, Wolfram Hubert / Schüttler, Christian Gisbert / Glebe, Dieter -- 2.14 Unmet needs in chronic kidney disease testing / Jones, Graham -- 2.15 Towards a national chronic kidney disease testing program / Jones, Graham -- 2.16 Biochemistry and metabolism of vitamin D / Jones, Glenville -- 2.17 Diagnostics of thalassemia / Kaeslin, Martha / Brunner-Agten, Saskia / Huber, Andreas R. -- 2.18 The specific roles of assessors during accreditation / Huisman, Wim -- 2.19 Laboratory diagnosis of hereditary spherocytosis / King, May-Jean -- 2.20 Quantification of blood folate forms using stable-isotope dilution ultra performance liquid chromatography tandem mass spectrometry / Kirsch, Susanne H. / Herrmann, Wolfgang / Obeid, Rima -- 2.21 Evaluation of the new Marburg cerebrospinal fluid model with human spondylopathies / Kleine, Tilmann Otto / Löwer, Christa / Bien, Siegfried / Lehmitz, Reinhardt / Dorn-Beineke, Alexandra -- 2.22 E-learning experiences of national societies of clinical chemistry and laboratory medicine / Kocna, Petr -- 2.23 The experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings / Kosack, Cara S. -- 2.24 Screening, identifying, and quantifying small molecules by hyphenated mass spectrometry in toxicology and drug monitoring - an update / Maurer, Hans H. -- 2.25 Analytical quality in the Latin America area / Migliarino, Gabriel Alejandro -- 2.26 Standardization in molecular diagnostics: definitions and uses of nucleic acid reference materials / Payne, Deborah A. / Rousseau, François / Mamotte, Cyril D.S. / Gancberg, David / Schaik, Ron H.N. van / Schimmel, Heinz / Pazzagli, Mario -- 2.27 Profiling of antiphospolipid antibodies - association with cerebrovascular events in APS / Roggenbuck, Dirk -- 2.28 Plasma levels of soluble CD30 and CD40L in pediatric patients after liver transplantation / Shevchenko, Olga P. / Tsirulnikova, Olga M. / Gichkun, Olga E. / Kurabekova, Rivada M. / Ammosov, Aleksandr A. / Gautier, Sergey V. -- 2.29 Diagnostic and prognostic value of presepsin (soluble CD14 subtype) in emergency patients with early sepsis using the new assay PATHFAST presepsin / Spanuth, Eberhard / Ebelt, Henning / Ivandic, Boris / Werdan, Karl -- 2.30 Diagnostic workup of primary aldosteronism / Stowasser, Michael -- 2.31 What should the clinical laboratory and the toxicologist-pharmacologist offer the poisoned patient? / Uges, Donald R.A. -- 2.32 Novel aspects of the von Willebrand factor - platelet glycoprotein IB interaction and signaling / Walter, Ulrich / Gambaryan, Stepan / Herterich, Sabine / Lohmann, |